Home
>
National Drug Code (NDC)
>
Doxazosin
Doxazosin - 0093-2069-01 - (Doxazosin Mesylate)
Drug Information of Doxazosin
| Product NDC: | 0093-2069 |
| Proprietary Name: | Doxazosin |
| Non Proprietary Name: | Doxazosin Mesylate |
| Active Ingredient(s): | 2 mg/1 & nbsp; Doxazosin Mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Doxazosin
| Product NDC: | 0093-2069 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075536 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130329 |
Package Information of Doxazosin
| Package NDC: | 0093-2069-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0093-2069-01) |
NDC Information of Doxazosin
| NDC Code | 0093-2069-01 |
| Proprietary Name | Doxazosin |
| Package Description | 100 TABLET in 1 BOTTLE (0093-2069-01) |
| Product NDC | 0093-2069 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Doxazosin Mesylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130329 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | DOXAZOSIN MESYLATE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
